Methyl (3R)-3-[5-[(2S)-2-methylpiperidin-1-yl]-3-pyridinyl]-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
C20H31N3O4 — CID 139580121
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl (3R)-3-[5-[(2S)-2-methylpiperidin-1-yl]-3-pyridinyl]-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
Methyl (3R)-3-[5-[(2S)-2-methylpiperidin-1-yl]-3-pyridinyl]-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate (PubChem CID 139580121) has the molecular formula C20H31N3O4 and a molecular weight of 377.49 g/mol. Its IUPAC name is methyl (3R)-3-[5-[(2S)-2-methylpiperidin-1-yl]-3-pyridinyl]-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate.
Molecular Properties
| Compound Name | Methyl (3R)-3-[5-[(2S)-2-methylpiperidin-1-yl]-3-pyridinyl]-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate |
|---|---|
| PubChem CID | 139580121 |
| Molecular Formula | C20H31N3O4 |
| Molecular Weight | 377.49 g/mol |
| Exact Mass | 377.23 |
| IUPAC Name | methyl (3R)-3-[5-[(2S)-2-methylpiperidin-1-yl]-3-pyridinyl]-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate |
| SMILES | COC(=O)C[C@@H](NC(=O)OC(C)(C)C)c1cncc(N2CCCC[C@@H]2C)c1 |
| InChI | InChI=1S/C20H31N3O4/c1-14-8-6-7-9-23(14)16-10-15(12-21-13-16)17(11-18(24)26-5)22-19(25)27-20(2,3)4/h10,12-14,17H,6-9,11H2,1-5H3,(H,22,25)/t14-,17+/m0/s1 |
| InChIKey | NMKBEPSYFWDYNT-WMLDXEAASA-N |
| XLogP | 3.59 |
| TPSA | 80.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 377.49 |
| LogP ≤ 5 | 3.59 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139580121 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.